Graft CD8 T‐cell‐based risk system predicts survival in antithymocyte globulin‐based myeloablative haploidentical peripheral blood stem cell transplantation.

Autor: Zhu, Panpan1,2,3,4, Yang, Luxin1,2,3,4, Wu, Yibo1,2,3,4, Shi, Jimin1,2,3,4, Lai, Xiaoyu1,2,3,4, Liu, Lizhen1,2,3,4, Ye, Yishan1,2,3,4, Yu, Jian1,2,3,4, Zhao, Yanmin1,2,3,4, Yuan, Xiaolin1,2,3,4, Fu, Huarui1,2,3,4, Cai, Zhen1,2,3,4, Huang, He1,2,3,4 huanghe@zju.edu.cn, Luo, Yi1,2,3,4 luoyijr@zju.edu.cn
Zdroj: Clinical & Translational Immunology. 2024, Vol. 13 Issue 1, p1-12. 12p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje